RT Journal Article
SR Electronic
T1 Safety and efficacy of nivolumab plus ipilimumab in patients with advanced non-clear cell renal cell carcinoma: results from the phase 3b/4 CheckMate 920 trial
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e003844
DO 10.1136/jitc-2021-003844
VO 10
IS 2
A1 Tykodi, Scott S
A1 Gordan, Lucio N
A1 Alter, Robert S
A1 Arrowsmith, Edward
A1 Harrison, Michael R
A1 Percent, Ivor
A1 Singal, Rakesh
A1 Van Veldhuizen, Peter
A1 George, Daniel J
A1 Hutson, Thomas
A1 Zhang, Joshua
A1 Zoco, Jesus
A1 Johansen, Jennifer L
A1 Rezazadeh Kalebasty, Arash
YR 2022
UL http://jitc.bmj.com/content/10/2/e003844.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.